1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 41, 12/Oct/2017
  4. Article
Surveillance and outbreak report Open Access
Like 0
Download

Abstract

Diagnostic criteria of Creutzfeldt–Jakob disease (CJD), a rare and fatal transmissible nervous system disease with public health implications, are determined by clinical data, electroencephalogram (EEG), detection of 14-3-3 protein in cerebrospinal fluid (CSF), brain magnetic resonance imaging and prion protein gene examination. The specificity of protein 14-3-3 has been questioned. We reviewed data from 1,572 autopsied patients collected over an 18-year period (1992–2009) and assessed whether and how 14-3-3 detection impacted the diagnosis of sporadic CJD in France, and whether this led to the misdiagnosis of treatable disorders. 14-3-3 detection was introduced into diagnostic criteria for CJD in 1998. Diagnostic accuracy decreased from 92% for the 1992–1997 period to 85% for the 1998–2009 period. This was associated with positive detections of 14-3-3 in cases with negative EEG and alternative diagnosis at autopsy. Potentially treatable diseases were found in 163 patients (10.5%). This study confirms the usefulness of the recent modification of diagnosis criteria by the addition of the results of CSF real-time quaking-induced conversion, a method based on prion seed-induced misfolding and aggregation of recombinant prion protein substrate that has proven to be a highly specific test for diagnosis of sporadic CJD.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.41.16-00715
2017-10-12
2024-11-22
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.41.16-00715
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/41/eurosurv-22-41-4.html?itemId=/content/10.2807/1560-7917.ES.2017.22.41.16-00715&mimeType=html&fmt=ahah

References

  1. Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alpérovitch A. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology. 2000;54(5):1095-9.  https://doi.org/10.1212/WNL.54.5.1095  PMID: 10720280 
  2. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659-68.  https://doi.org/10.1093/brain/awp191  PMID: 19773352 
  3. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology. 2001;56(11):1528-33.  https://doi.org/10.1212/WNL.56.11.1528  PMID: 11402110 
  4. Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011;70(3):437-44.  https://doi.org/10.1002/ana.22454  PMID: 21674591 
  5. Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, Chatelain J, Beaudry P, Alpérovitch A, et al. Molecular genetics of prion diseases in France. Neurology. 1994;44(12):2347-51.  https://doi.org/10.1212/WNL.44.12.2347  PMID: 7991124 
  6. Alpérovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 1999;353(9165):1673-4.  https://doi.org/10.1016/S0140-6736(99)01342-2  PMID: 10335789 
  7. Privat N, Sazdovitch V, Seilhean D, LaPlanche JL, Hauw JJ. PrP immunohistochemistry: different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt-Jakob disease. Microsc Res Tech. 2000;50(1):26-31.  https://doi.org/10.1002/1097-0029(20000701)50:1<26::AID-JEMT5>3.0.CO;2-S  PMID: 10871545 
  8. Hauw JJ, Sazdovitch V, Laplanche JL, Peoc’h K, Kopp N, Kemeny J, et al. Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology. 2000;54(8):1641-6.  https://doi.org/10.1212/WNL.54.8.1641  PMID: 10762506 
  9. Levavasseur E, Laffont-Proust I, Morain E, Faucheux BA, Privat N, Peoc’h K, et al. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease--implications for the dissemination and the diagnosis of human prion strains. PLoS One. 2008;3(7):e2786.  https://doi.org/10.1371/journal.pone.0002786  PMID: 18665216 
  10. Privat N, Laffont-Proust I, Faucheux BA, Sazdovitch V, Frobert Y, Laplanche JL, et al. Human prion diseases: from antibody screening to a standardized fast immunodiagnosis using automation. Mod Pathol. 2008;21(2):140-9. PMID: 18084251 
  11. Brandel JP, Peckeu L, Haïk S. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol. 2013;20(4):395-7.  https://doi.org/10.1016/j.tracli.2013.02.029  PMID: 23587616 
  12. Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013;84(12):1372-7.  https://doi.org/10.1136/jnnp-2012-304820  PMID: 23965290 
  13. Court L, Hauw JJ. Le docteur Francoise Cathala Pagesy et l’histoire des maladies à prions. Rev Neurol (Paris). 2015;171(12):805-11.  https://doi.org/10.1016/j.neurol.2014.02.003  PMID: 24703683 
  14. de Pedro-Cuesta J, Glatzel M, Almazán J, Stoeck K, Mellina V, Puopolo M, et al. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health. 2006;6(1):278.  https://doi.org/10.1186/1471-2458-6-278  PMID: 17096829 
  15. Zanusso G, Fiorini M, Farinazzo A, Gelati M, Benedetti MD, Ferrari S, et al. Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients. Neurology. 2005;64(9):1618-20.  https://doi.org/10.1212/01.WNL.0000160397.81314.84  PMID: 15883327 
  16. Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol. 2004;251(3):298-304.  https://doi.org/10.1007/s00415-004-0311-9  PMID: 15015009 
  17. Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350-9.  https://doi.org/10.1093/brain/awm063  PMID: 17472986 
  18. Gelpi E, Heinzl H, Hoftberger R, Unterberger U, Strobel T, Voigtlander T, et al. Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study. Neuroepidemiology. 2008;30(4):215-21.  https://doi.org/10.1159/000126915  PMID: 18424902 
  19. Jansen C, Parchi P, Capellari S, Ibrahim-Verbaas CA, Schuur M, Strammiello R, et al. Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. PLoS One. 2012;7(4):e36333.  https://doi.org/10.1371/journal.pone.0036333  PMID: 22558438 
  20. Barash JA, West JK, DeMaria A Jr. Accuracy of administrative diagnostic data for pathologically confirmed cases of Creutzfeldt-Jakob disease in Massachusetts, 2000-2008. Am J Infect Control. 2014;42(6):659-64.  https://doi.org/10.1016/j.ajic.2014.02.002  PMID: 24721779 
  21. Paterson RW, Torres-Chae CC, Kuo AL, Ando T, Nguyen EA, Wong K, et al. Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol. 2012;69(12):1578-82.  https://doi.org/10.1001/2013.jamaneurol.79  PMID: 23229042 
  22. Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043-57.  https://doi.org/10.1093/brain/awq216  PMID: 20855418 
  23. Begué C, Martinetto H, Schultz M, Rojas E, Romero C, D’Giano C, et al. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008. Neuroepidemiology. 2011;37(3-4):193-202.  https://doi.org/10.1159/000331907  PMID: 22067221 
  24. Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231.  https://doi.org/10.1371/journal.pone.0024231  PMID: 21904617 
  25. Soomro S, Mohan C. Biomarkers for sporadic Creutzfeldt-Jakob disease. Ann Clin Transl Neurol. 2016;3(6):465-72. https://doi.org/10.1002/acn3.304  PMID: 27547775 
  26. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175-8.  https://doi.org/10.1038/nm.2294  PMID: 21278748 
  27. McGuire LI, Peden AH, Orrú CD, Wilham JM, Appleford NE, Mallinson G, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012;72(2):278-85.  https://doi.org/10.1002/ana.23589  PMID: 22926858 
  28. McGuire LI, Poleggi A, Poggiolini I, Suardi S, Grznarova K, Shi S, et al. Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: An international study. Ann Neurol. 2016;80(1):160-5.  https://doi.org/10.1002/ana.24679  PMID: 27130376 
  29. Zanusso G, Monaco S, Pocchiari M, Caughey B. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol. 2016;12(6):325-33.  https://doi.org/10.1038/nrneurol.2016.65  PMID: 27174240 
Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Laurene+Peckeu&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Peckeu Laurene</a>, <a href="/search?value1=Nicole+Delasnerie-Laupr%C3%A8tre&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Delasnerie-Lauprètre Nicole</a>, <a href="/search?value1=Jean-Philippe+Brandel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Brandel Jean-Philippe</a>, <a href="/search?value1=Dominique+Salomon&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Salomon Dominique</a>, <a href="/search?value1=V%C3%A9ronique+Sazdovitch&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sazdovitch Véronique</a>, <a href="/search?value1=Jean-Louis+Laplanche&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Laplanche Jean-Louis</a>, <a href="/search?value1=Charles+Duyckaerts&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Duyckaerts Charles</a>, <a href="/search?value1=Danielle+Seilhean&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Seilhean Danielle</a>, <a href="/search?value1=St%C3%A9phane+Ha%C3%AFk&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Haïk Stéphane</a>, <a href="/search?value1=Jean-Jacques+Hauw&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hauw Jean-Jacques</a></span>. Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(41):pii=16-00715. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.41.16-00715" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.41.16-00715</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 03 Nov 2016;&nbsp;&nbsp; <span class="generated">Accepted</span>: 02 Apr 2017 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.41.16-00715
/content/10.2807/1560-7917.ES.2017.22.41.16-00715
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error